Merck & Co (MRK)

$125.85 0.00 (0.00%)

17:00 EDT MRK Stock Quote Delayed 30 Minutes

The 3 Best ESG Stocks to Buy in August

By Josh Enomoto, InvestorPlace Contributor Aug 10, 2023

Although doing right would seem to come at a cost to shareholder profit potential, these best ESG stocks to buy prove otherwise.

The 3 Best Healthcare Stocks to Buy in August

3 Pharma Stocks to Buy for Their Promising Progress

7 Dow Stocks to Buy as Recession Fears Roll Back

Volume:

Previous Close -

Market Cap 318.57B

PE Ratio 139.83

EPS 0.9

Volume (Avg. Vol.) 59

Day's Range -

52-Week Range $99.14 - $134.63

Dividend & Yield $2.92 (2.32%)

MRK Stock Predictions, Articles, and Merck & Co News

7 Safe Stocks to Buy as Fed Gears Up for Disinflation

By Josh Enomoto, InvestorPlace Contributor Jul 18, 2023

With a hawkish monetary policy the possible outcome of the Federal Reserve impact, these are the safe stocks to buy right now.

Retirement Stocks: Here’s Where to Invest $1,000 Right Now

By Jeremy Flint, InvestorPlace Contributor Jul 7, 2023

Finding a “good” retirement stock suitable for all investors’ portfolios is nearly impossible. Variables depend on your retirement account’s tax structure, age, risk tolerance, and…

The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023

By Joel Baglole, InvestorPlace Contributor Jun 30, 2023

Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks.

The 3 Best Defensive Stocks to Buy in June 2023

By Josh Enomoto, InvestorPlace Contributor Jun 7, 2023

With market and economic concerns rising, investors may find comfort targeting these ideas for the best defensive stocks to buy.

3 Undervalued Dow Stocks to Buy Before Wall Street Does

By Larry Ramer, InvestorPlace Contributor Jun 2, 2023

The Street is down on the blue-chip index, but these undervalued Dow Jones stocks should generate big profits for long-term investors.

7 Dividend Stocks to Buy (and Never Sell)

By Thomas Niel, InvestorPlace Contributor May 31, 2023

So, what are some of the best long-term dividend stocks to buy right now? Consider these seven. Each one offers a solid yield, has a track record of steady dividend growth, and is reasonably-priced to boot.

3 Innovative Growth Stocks to Buy for Next-Gen Profits

By Faisal Humayun, InvestorPlace Contributor May 31, 2023

These are the innovative growth stocks for future profits and these stocks are poised for multibagger returns.

7 Stocks That Could Be the Next $2 Trillion-Dollar Companies

By Larry Ramer, InvestorPlace Contributor May 23, 2023

AI, the cloud transition and success in the pharmaceutical sector will help these firms become $2 trillion companies.

3 Undervalued Pharma Stocks to Buy for High Total Returns

By Faisal Humayun, InvestorPlace Contributor May 19, 2023

These are the undervalued pharma stocks to buy for high total returns as these companies are poised for steady growth and cash flow upside.

Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs

By Bret Kenwell, InvestorPlace Contributor May 17, 2023

Investors are busy looking at tech stocks, but they should be looking for healthcare stocks to buy, as this group powers to new highs.

The 7 Best Stocks From Schwab’s Dividend ETF

By Chris Lau, InvestorPlace Contributor Apr 26, 2023

Investors may beat the market by cherry-picking the best dividend stocks from the Schwab income exchange-traded fund.

3 Pharma Stocks That Could See a Surge in Demand in 2023

By Muslim Farooque, InvestorPlace Contributor Apr 24, 2023

These pharma stocks to buy are poised for long-term growth in the trillion-dollar biotechnology space, offering tremendous upside ahead

Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?

By William White, InvestorPlace Writer Apr 17, 2023

Prometheus Biosciences (RXDX) stock is on the rise Monday after the company revealed a $10.8 billion acquisition deal with Merck (MRK).

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Apr 17, 2023

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Why Is Merck (MRK) Stock Up Today?

By William White, InvestorPlace Writer Apr 13, 2023

Merck (MRK) stock is on the move Thursday after the pharmaceutical company got an update from the FDA concerning Keytruda.

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

By Muslim Farooque, InvestorPlace Contributor Mar 21, 2023

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

7 Defensive Stocks to Buy During This Chaotic Spell

By Josh Enomoto, InvestorPlace Contributor Mar 20, 2023

With turmoil erupting on Wall Street over the banking sector crisis, investors should turn to reliable defensive stocks to buy.

3 Large-Cap Biotech Stocks to Hold for the Long Haul

By John Blankenhorn, InvestorPlace Contributor Feb 19, 2023

Three large-cap biotech stocks to buy and hold for the long haul

The 7 Most Undervalued Blue-Chip Stocks to Buy in February 2023

By Chris Markoch, InvestorPlace Contributor Feb 5, 2023

If you're looking for undervalued blue-chips, we've come up with a list of seven stocks that you can consider adding in February

The 7 Most Undervalued Dow Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

If you’re looking for the best deals among the most iconic enterprises, these are the most undervalued Dow stocks to buy.

Merck & Co (MRK)

The 3 Best ESG Stocks to Buy in August

The 3 Best Healthcare Stocks to Buy in August

3 Pharma Stocks to Buy for Their Promising Progress

7 Dow Stocks to Buy as Recession Fears Roll Back

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Merck & Co (MRK)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRK Stock Predictions, Articles, and Merck & Co News

Subscriber Sign in